Assenagon Asset Management S.A. Instil Bio, Inc. Transaction History

Assenagon Asset Management S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$0.4 - $0.63 $23,816 - $37,510	-59,541 Reduced 66.6%	29,857 $12,000
Q2 2023 Jul 25, 2023	SELL	$0.51 - $0.67 $25,439 - $33,420	-49,882 Reduced 35.81%	89,398 $49,000
Q1 2023 Apr 18, 2023	BUY	$0.6 - $0.91 $83,568 - $126,744	139,280 New	139,280 $91,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.84B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.